BRIEF published on 04/13/2026 at 17:07, 6 months 22 days ago Marinomed Biotech AG finalise avec succès son augmentation de capital Augmentation De Capital Confiance Des Investisseurs Bourse De Vienne Actions Émises Biotechnologie Marinomed
BRIEF published on 04/13/2026 at 17:07, 6 months 22 days ago Marinomed Biotech AG Completes Successful Capital Increase Capital Increase Investor Confidence Vienna Stock Exchange Marinomed Biotech Shares Issued
PRESS RELEASE published on 04/13/2026 at 17:02, 6 months 22 days ago Marinomed secures financing through successful capital increase Marinomed Biotech AG successfully completes capital increase, securing EUR 2.23 million in gross proceeds. Financing to support company's milestones and flagship products marketing Financing Capital Increase Marinomed Biotech AG Rights Offering Marinosolv Technology
BRIEF published on 03/23/2026 at 17:49, 7 months 13 days ago Marinomed Biotech AG: Capital Increase and 2025 Financial Outlook Capital Increase Marinomed 2025 Results Liquidity Gap Shareholder Opportunity
BRIEF published on 03/23/2026 at 17:49, 7 months 13 days ago Marinomed Biotech AG : Augmentation de capital et perspectives financières pour 2025 Augmentation De Capital Marinomed Résultats 2025 Déficit De Liquidités Opportunité Pour Les Actionnaires
PRESS RELEASE published on 03/23/2026 at 17:44, 7 months 13 days ago Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research issues a Buy recommendation with a target price of EUR 50 for Marinomed Biotech AG due to a capital increase and delayed Carragelose earn-out revenues First Berlin Equity Research Buy Recommendation Capital Increase Marinomed Biotech AG Carragelose Earn-out
BRIEF published on 03/19/2026 at 16:52, 7 months 17 days ago Marinomed Biotech Initiates Capital Increase with Subscription Rights Capital Increase Subscription Rights Marinomed Biotech Fiscal Outlook Liquidity Gap
BRIEF published on 03/19/2026 at 16:52, 7 months 17 days ago Marinomed Biotech lance une augmentation de capital par souscription de droits Augmentation De Capital Biotechnologie Marinomed Droits D'abonnement Perspectives Budgétaires Déficit De Liquidités
PRESS RELEASE published on 03/19/2026 at 16:47, 7 months 17 days ago Marinomed Biotech Announces Capital increase with subscription rights Marinomed Biotech plans a capital increase with subscription rights supported by an institutional investor to meet short-term capital needs. Preliminary financial figures for 2025 show revenue growth Capital Increase Financial Figures Subscription Rights Marinomed Biotech Institutional Investor
BRIEF published on 03/19/2026 at 16:19, 7 months 17 days ago Marinomed Biotech AG Initiates Cash Capital Increase Capital Increase Subscription Rights Marinomed Biotech Carragelose Transfer Short-term Liquidity
Published on 11/06/2026 at 05:15, 3 hours 35 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 7 hours 57 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 8 hours 5 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 8 hours 55 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/06/2026 at 08:00, 50 minutes ago Gledhow Investments plc: Strategic Update: Originating the Next Generation of Listed Natural Resources Companies; Issue of Equity and Repayment of all outstanding Debt
Published on 11/06/2026 at 08:00, 50 minutes ago Schweizer Electronic AG continues on its growth trajectory and achieves a turnaround in earnings in the third quarter
Published on 11/06/2026 at 07:30, 1 hour 20 minutes ago Baader Bank launches Baader Trading Charity Weeks in support of BILD hilft e.V. „Ein Herz für Kinder“
Published on 11/06/2026 at 07:00, 1 hour 50 minutes ago ARYZTA announces upcoming departure of its CFO
Published on 11/05/2026 at 18:21, 14 hours 28 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 14 hours 28 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
